Neonatal Intrahepatic Cholestasis Due To Citrin Deficiency
Description
Neonatal intrahepatic cholestasis due to citrin deficiency is a mild subtype of citrin deficiency (see this term) characterized clinically by low birth weight, failure to thrive, transient intrahepatic cholestasis, multiple aminoacidemia, galactosemia, hypoproteinemia, hepatomegaly, decreased coagulation factors, hemolytic anemia, variable but mostly mild liver dysfunction, and hypoglycemia.
Genes related to Neonatal Intrahepatic Cholestasis Due To Citrin Deficiency
- SLC25A13
Clinical Features
Top most frequent phenotypes and symptoms related to Neonatal Intrahepatic Cholestasis Due To Citrin Deficiency
- Global developmental delay
- Growth delay
- Failure to thrive
- Anemia
- Hepatomegaly
- Jaundice
- Hypoglycemia
- Abnormality of the nervous system
- Abnormality of the liver
- Small for gestational age
And another 19 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Neonatal Intrahepatic Cholestasis Due To Citrin Deficiency Is also known as cholestasis, neonatal intrahepatic, caused by citrin deficiency, neonatal intrahepatic cholestasis caused by citrin deficiency, citrullinemia, type ii, neonatal-onset, with or without failure to thrive and dyslipidemia, niccd.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Neonatal Intrahepatic Cholestasis Due To Citrin Deficiency Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
MitoMet®Plus aCGH Analysis.
By Baylor Miraca Genetics Laboratories (United States).
RGS9, RHO, GRK1, RLBP1, RNASEL, BCS1L, RP1, RP2, RP9, RPE65, RPGR, RPL35A, MRPL3, RPS14, RS1, SAG, SARDH, SCO2, SCP2, SDHB , (...)
View the complete list with 612 more genes
Specificity
1 %
Genes
100 % |
SLC25A13 Sequence Analysis.
By Baylor Miraca Genetics Laboratories (United States).
SLC25A13
Specificity
100 %
Genes
100 % |
SLC25A13 Deletion/Duplication Analysis.
By Baylor Miraca Genetics Laboratories (United States).
SLC25A13
Specificity
100 %
Genes
100 % |
SLC25A13 Sequence Analysis (Prenatal Diagnosis).
By Baylor Miraca Genetics Laboratories (United States).
SLC25A13
Specificity
100 %
Genes
100 % |
SLC25A13 Comprehensive - Sequence & Deletion/Duplication Analysis.
By Baylor Miraca Genetics Laboratories (United States).
SLC25A13
Specificity
100 %
Genes
100 % |
GeneAware Complete Panel Version 2 (Female).
By Baylor Miraca Genetics Laboratories (United States).
RMRP, BCS1L, SACS, BLM, SGCA, SGCB, SGCG, SGSH, SLC12A6, SLC17A5, SLC22A5, SLC25A13, SLC25A15, SLC26A2, SLC35A3, SLC7A7, SMN1, SMPD1, BTD, BTK , (...)
View the complete list with 139 more genes
Specificity
1 %
Genes
100 % |
GeneAware Complete Panel Version 2 (Male).
By Baylor Miraca Genetics Laboratories (United States).
RMRP, BCS1L, SACS, BLM, SGCA, SGCB, SGCG, SGSH, SLC12A6, SLC17A5, SLC22A5, SLC25A13, SLC25A15, SLC26A2, SLC35A3, SLC7A7, SMN1, SMPD1, BTD, TGM1 , (...)
View the complete list with 129 more genes
Specificity
1 %
Genes
100 % |
Cholestasis.
By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).
SLC25A13, ATP8B1, AKR1D1, ABCB4, JAG1
Specificity
20 %
Genes
100 % |
You can get up to 68 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
MESH OMIM ORPHANET Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1 HYPOBETALIPOPROTEINEMIA, FAMILIAL, 1; FHBL1 EPILEPSY, HOT WATER, 1; HWE1